| Synonym |
|---|
| nsc56858 |
| 11-(3-pentyl-2-oxiranyl)-9-undecenoic acid |
| (e)-11-(3-pentyloxiran-2-yl)undec-9-enoic acid |
| CHEMBL281291 , |
| 12,13-epome(9) |
| 6799-85-5 |
| CHEBI:165794 |
| bdbm50280208 |
| (e)-11-(3-pentyl-oxiranyl)-undec-9-enoic acid |
| 11-(3-pentyloxiran-2-yl)undec-9-enoic acid |
| 17966-13-1 |
| (z)-11-[(2r,3s)-3-pentyloxiran-2-yl]undec-9-enoic acid |
| 12,13-epoxy-9-octadecenoic acid |
| LMFA02000276 |
| 9-undecenoic acid, 11-(3-pentyl-2-oxiranyl)- |
| 11-(3-pentyl-2-oxiranyl)-9-undcenoic acid |
| 12,13-eode |
| Substance | Studies | Classes | Roles | First Year | Last Year | Average Age | Relationship Strength | Trials | pre-1990 | 1990's | 2000's | 2010's | post-2020 |
|---|
| palmitic acid | | long-chain fatty acid;
straight-chain saturated fatty acid | algal metabolite;
Daphnia magna metabolite;
EC 1.1.1.189 (prostaglandin-E2 9-reductase) inhibitor;
plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
| 14,15-epoxy-5,8,11-eicosatrienoic acid | | long-chain fatty acid | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
| 17-octadecynoic acid | | acetylenic fatty acid;
long-chain fatty acid;
monounsaturated fatty acid;
terminal acetylenic compound | EC 1.14.14.94 (leukotriene-B4 20-monooxygenase) inhibitor;
EC 1.14.15.3 (alkane 1-monooxygenase) inhibitor;
P450 inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
| 2-fluorohexadecanoic acid | | fluoro fatty acid;
long-chain fatty acid | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
| alpha-hydroxymyristic acid | | 2-hydroxy fatty acid;
long-chain fatty acid | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
| 5,8,11,14-eicosatetraynoic acid | | long-chain fatty acid | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
| 5,8,11-eicosatriynoic acid | | acetylenic fatty acid;
icosanoid;
long-chain fatty acid;
polyunsaturated fatty acid | EC 1.13.11.31 (arachidonate 12-lipoxygenase) inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
| eicosa-11,14-dienoic acid | | long-chain fatty acid | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
| stearic acid | | long-chain fatty acid;
saturated fatty acid;
straight-chain saturated fatty acid | algal metabolite;
Daphnia magna metabolite;
human metabolite;
plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
| behenic acid | | long-chain fatty acid;
straight-chain saturated fatty acid | plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
| malvalic acid | | cyclopropenyl fatty acid;
long-chain fatty acid;
monounsaturated fatty acid | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
| phytomonic acid | | carbocyclic fatty acid;
long-chain fatty acid;
saturated fatty acid | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
| margaric acid | | long-chain fatty acid;
straight-chain saturated fatty acid | algal metabolite;
Daphnia magna metabolite;
mammalian metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
| arachidic acid | | long-chain fatty acid;
straight-chain saturated fatty acid | plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
| myristic acid | | long-chain fatty acid;
straight-chain saturated fatty acid | algal metabolite;
Daphnia magna metabolite;
EC 3.1.1.1 (carboxylesterase) inhibitor;
human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
| tridecanoic acid | | long-chain fatty acid;
straight-chain saturated fatty acid | plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
| nonadecanoic acid | | long-chain fatty acid;
straight-chain saturated fatty acid | fungal metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
| sterculic acid | | cyclopropenyl fatty acid;
long-chain fatty acid;
monounsaturated fatty acid | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
| pentadecanoic acid | | long-chain fatty acid;
straight-chain saturated fatty acid | algal metabolite;
Daphnia magna metabolite;
food component;
human blood serum metabolite;
plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
| beta-hydroxymyristic acid | | 3-hydroxy fatty acid;
3-hydroxy monocarboxylic acid;
long-chain fatty acid | bacterial metabolite;
human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
| heneicosanoic acid | | long-chain fatty acid;
straight-chain saturated fatty acid | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
| aseanostatin p5 | | branched-chain saturated fatty acid;
long-chain fatty acid | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
| isostearate | | branched-chain saturated fatty acid;
long-chain fatty acid;
methyl-branched fatty acid | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
| 14-methylhexadecanoic acid | | branched-chain saturated fatty acid;
long-chain fatty acid;
methyl-branched fatty acid | mammalian metabolite;
plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
| phytanic acid | | branched-chain saturated fatty acid;
long-chain fatty acid;
methyl-branched fatty acid | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
| tuberculostearic acid | | long-chain fatty acid;
methyl-branched fatty acid | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
| 2-bromopalmitate | | 2-bromocarboxylic acid;
bromo fatty acid;
long-chain fatty acid;
straight-chain fatty acid | fatty acid oxidation inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
| hydnocarpic acid | | cyclopentenyl fatty acid;
long-chain fatty acid;
monounsaturated fatty acid | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
| 15-hydroxyeicosanoic acid | | long-chain fatty acid | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
| 2-methylhexadecanoic acid | | branched-chain saturated fatty acid;
long-chain fatty acid;
methyl-branched fatty acid | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
| pristanic acid | | branched-chain saturated fatty acid;
long-chain fatty acid;
methyl-branched fatty acid | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
| 13-methyltetradecanoic acid | | branched-chain saturated fatty acid;
long-chain fatty acid;
methyl-branched fatty acid | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
| 2-hexadecynoic acid | | long-chain fatty acid | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
| 16-fluoropalmitic acid | | fluoro fatty acid;
long-chain fatty acid | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
| minquartynoic acid | | acetylenic fatty acid;
hydroxy polyunsaturated fatty acid;
long-chain fatty acid;
straight-chain fatty acid;
tetrayne | antimalarial;
antineoplastic agent;
antiviral agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
| 6-keto stearic acid | | long-chain fatty acid | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
| 10-ketostearic acid | | long-chain fatty acid | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
| arachidonic acid | | icosa-5,8,11,14-tetraenoic acid;
long-chain fatty acid;
omega-6 fatty acid | Daphnia galeata metabolite;
EC 3.1.1.1 (carboxylesterase) inhibitor;
human metabolite;
mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
| 3-methylhexadecanoic acid | | long-chain fatty acid | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
| osteoprotegerin | | long-chain fatty acid | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
| leukotriene a4 | | epoxy fatty acid;
leukotriene;
long-chain fatty acid;
oxylipin;
polyunsaturated fatty acid | human metabolite;
mouse metabolite;
plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
| leukotriene b4 | | dihydroxy monocarboxylic acid;
hydroxy polyunsaturated fatty acid;
leukotriene;
long-chain fatty acid | human metabolite;
mouse metabolite;
plant metabolite;
vasoconstrictor agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
| 8,11,14-eicosatrienoic acid | | fatty acid 20:3;
long-chain fatty acid | fungal metabolite;
human metabolite;
nutraceutical | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
| lipoxin a4 | | hydroxy polyunsaturated fatty acid;
lipoxin;
long-chain fatty acid | human metabolite;
metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
| ethamolin | | long-chain fatty acid | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
| 18-methyleicosanoic acid | | branched-chain saturated fatty acid;
long-chain fatty acid;
methyl-branched fatty acid | mammalian metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
| 10-octadecenoic acid, (z)-isomer | | long-chain fatty acid | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
| 12-octadecenoic acid | | long-chain fatty acid | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
| 9,10-dihydroxy-12-octadecenoic acid | | long-chain fatty acid | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
| 9,10,13-trihydroxy-11-octadecenoic acid | | long-chain fatty acid;
monounsaturated fatty acid;
straight-chain fatty acid;
TriHOME | human blood serum metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
| meteneprost | | long-chain fatty acid | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
| leukotriene b5 | | dihydroxy monocarboxylic acid;
hydroxy polyunsaturated fatty acid;
leukotriene;
long-chain fatty acid | anti-inflammatory agent;
human xenobiotic metabolite;
rat metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
| al 8810 | | long-chain fatty acid | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
| 7,7-dimethyl-5,8-eicosadienoic acid | | long-chain fatty acid | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
| stearidonic acid | | long-chain fatty acid;
octadecatetraenoic acid;
omega-3 fatty acid | Daphnia galeata metabolite;
mouse metabolite;
plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
| ximenynic acid | | long-chain fatty acid | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
| 12-hydroxy-8,10-heptadecadienoic acid | | long-chain fatty acid | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
| 12-hydroxy-5,8,10-heptadecatrienoic acid | | hydroxy polyunsaturated fatty acid;
long-chain fatty acid;
trienoic fatty acid | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
| 10-hydroxy-8-octadecenoic acid | | long-chain fatty acid | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
| limaprost | | long-chain fatty acid | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
| 5-oxo-15-hydroxy-6,8,11,13-eicosatetraenoic acid | | enone;
hydroxy polyunsaturated fatty acid;
icosanoid;
long-chain fatty acid;
oxo fatty acid;
secondary allylic alcohol | human xenobiotic metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
| 5,12-dihydroxy-6,8,14-eicosatrienoic acid | | dihydroxy monocarboxylic acid;
hydroxy polyunsaturated fatty acid;
leukotriene;
long-chain fatty acid | human urinary metabolite;
human xenobiotic metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
| sphingofungin b | | long-chain fatty acid | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
| antibiotic 1233a | | long-chain fatty acid | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
| colneleic acid | | divinyl ether fatty acid;
long-chain fatty acid;
straight-chain fatty acid | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
| eicosa-8,11,14-trien-5-ynoic acid | | long-chain fatty acid | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
| octadecenedioic acid | | long-chain fatty acid | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
| 10-hydroxystearic acid | | hydroxy fatty acid;
long-chain fatty acid | bacterial xenobiotic metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
| 2-hydroxy-9-cis-octadecenoic acid | | 2-hydroxy fatty acid;
hydroxy monounsaturated fatty acid;
long-chain fatty acid | antihypertensive agent;
antineoplastic agent;
apoptosis inducer | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
| 5s,12r,18r-trihydroxy-6z,8e,10e,14z,16e-eicosapentaenoic acid | | hydroxy polyunsaturated fatty acid;
long-chain fatty acid;
nonclassic icosanoid;
resolvin;
triol | anti-inflammatory agent;
human xenobiotic metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
| sphingofungin f | | long-chain fatty acid | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
| Lyngbic acid | | long-chain fatty acid | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
| sphingofungin e | | long-chain fatty acid | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
| 10-nitro-oleic acid | | long-chain fatty acid;
monounsaturated fatty acid;
nitro fatty acid | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
| etheroleic acid | | divinyl ether fatty acid;
long-chain fatty acid | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
| dicranin | | acetylenic fatty acid;
long-chain fatty acid;
straight-chain fatty acid;
trienoic fatty acid | antibacterial agent;
EC 1.13.11.33 (arachidonate 15-lipoxygenase) inhibitor;
metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
| 9-PAHSA | | FAHFA;
long-chain fatty acid | anti-inflammatory agent;
human metabolite;
hypoglycemic agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |